Is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?

Hantoushzadeh, Sedigheh; Saleh, Maasoumeh; Nouri, Behnaz; Panahi, Zahra

Hantoushzadeh, Sedigheh; Saleh, Maasoumeh; Nouri, Behnaz; Panahi, Zahra.

Hantoushzadeh S; Department of Fetal-Maternal Medicine, Tehran University of Medical Sciences, Imam Khomeini Hospital, Tehran, Iran. Electronic address: hantoushzadeh@tums.ac.ir.
Saleh M; Department of Fetal-Maternal Medicine, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran. Electronic address: salehmaasoumeh@yahoo.com.
Nouri B; Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran.
Panahi Z; Department of Obstetrics and Gynecology, Maternal-Fetal Neonatal Research Center, Tehran University of Medical Sciences, Valiasr Hospital, Tehran, Iran.

Pregnancy Hypertens ; 27: 27-28, 2022 03.

Article in English | MEDLINE | ID: covidwho-1510193

Subject(s)

COVID-19; Pre-Eclampsia; Aspirin/therapeutic use; Female; Humans; Platelet Aggregation Inhibitors/therapeutic use; Pre-Eclampsia/etiology; Pregnancy; Risk Factors; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pre-Eclampsia / COVID-19 Type of study: Prognostic study Limits: Female / Humans / Pregnancy Language: English Journal: Pregnancy Hypertens Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google